On Thursday, September 17, 2015, officials announced the locations for the first four Bellwether trials in the Xarelto Multi-District Lawsuit (MDL) case, which now includes well over 1200 individual Xarelto lawsuits.
The Xarelto lawsuit MDL case is currently being overseen by U.S. District Court Judge Eldon Fallon, who presides over the court in the Eastern District of Louisiana. It was announced on September 17 that the first four Bellwether trials would occur in the following three locations:
- The U.S. District Court for the Eastern District of Louisiana for the first two cases, scheduled for August 1, 2016 and August 22, 2016;
- The U.S. District Court for the South District of Texas for the third case, scheduled for September 12, 2016; and
- The U.S. District Court for the Southern District of Mississippi for the fourth case, scheduled for October 17, 2016.
Judge Fallon recommended that a total of 50 cases should be selected to serve as Bellwether trials for this ever-growing MDL case.
What are the Bellwether Trials and the Xarelto MDL?
Bellwether trials are trials involving specially selected cases, which are chosen because they are found to be substantially similar to multiple other cases in a MDL case, which is a consolidation of multiple cases with very similar facts. The cases in an MDL are all tried and/or settled separately, but they share some elements of the pre-trial process, such as evidence discovery.
The results of the Bellwether trials will provide both the plaintiffs and the defendants with valuable insight into the viability of the remaining cases in the MDL. Based on the results of these Bellwether trials, the plaintiffs and defendants can make an educated decision as to whether they wish to pursue a trial or arrive at a settlement, thereby negating the need for a trial.
As of mid-July 2015, there were over 1230 cases in Xarelto Lawsuit MDL case 2592 versus defendants Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Healthcare — the manufacturers of the dangerous blood thinner Xarelto (Rivaroxaban). More than 800 Xarelto lawsuits were added to the MDL in just one month.
The plaintiffs in the Xarelto lawsuits have four collective claims:
- They claim that they were never properly informed that Xarelto lacks an antidote or reversal agent to stop bleeding.
- They claim it was negligent to release a blood thinner drug that did not have an antidote or reversal agent.
- They claim the anticoagulant drug’s marketing understated the risks and side effects. Some also criticize the drug’s lack of a serious warning label.
- They claim that Xarelto’s marketing overstated the benefits of using this blood thinner drug in place of the traditional option, Coumadin/Warfarin.
Xarelto is prescribed to many patients, including those suffering from deep-vein thrombosis, pulmonary embolism, and non-valvular atrial fibrillation. It’s also prescribed to patients who’ve recently undergone hip replacement and knee replacement surgeries, to prevent potentially deadly blood clots.
Xarelto side effects are many and varied, ranging from bruising and heavy menstrual cycles, to intestinal bleeding, kidney bleeding, stroke and brain hemorrhage, ultimately leading to death. Studies have revealed that three-quarters of the uncontrollable bleeding cases involved patients age 75 and older. Another study found that the average age of those who died from Xarelto was 82 years old.
Filing Xarelto Lawsuits
Did you or a loved one suffer serious or deadly Xarelto side effects or complications? If so, you may be eligible to receive financial compensation for all of your losses, including medical bills, pain and suffering and lost wages.
The experienced legal team at The Meldofsky Firm is committed to helping clients navigate the potentially confusing legal process as they work to get the financial compensation they rightfully deserve.
Let our team at The Meldofsky Firm work for you. Remember, the law limits how long you have to file a case, so it’s important to take action soon. Call The Meldofsky Firm to discuss your case in a free and confidential case evaluation. Call 877-274-8672.